Generation of induced pluripotent stem cell line (VRISGi004-A) from a healthy female donor by reprogramming erythroid progenitor cells

Stem Cell Res. 2024 Apr:76:103331. doi: 10.1016/j.scr.2024.103331. Epub 2024 Feb 7.

Abstract

We generated a human induced pluripotent stem cell (hiPSC) line from erythroid progenitor cells (EPCs) of a 20-year-old female healthy donor using Sendai virus vector encoding Yamanaka factors OCT3/4, SOX2, c-MYC, and KLF4. The established hiPSCs showed a standard morphology and expression of typical undifferentiated stem cell markers, a normal karyotype (46, XX), and demonstrated potential for differentiation in vitro. Furthermore, they were successfully differentiated into cardiomyocytes that expressed cardiomyocyte-specific markers. The iPSC line and iPSC-derived cardiomyocytes will provide new avenues for future drug testing/development and personalized cell therapy for cardiovascular diseases (CVDs).

Keywords: Feeder-free; Induced cardiomyocytes; Sendai virus; Vietnamese iPSC line.

MeSH terms

  • Cardiovascular Diseases*
  • Cell Differentiation
  • Cellular Reprogramming
  • Erythroid Precursor Cells
  • Female
  • Humans
  • Induced Pluripotent Stem Cells* / metabolism
  • Kruppel-Like Factor 4
  • Young Adult

Substances

  • Kruppel-Like Factor 4